Home   HELP  /   AYUDA  /   求助 : help-desk@bctrials.org  /   (415) 476-5777 Click to print page  Print

Browse Trials


In response to COVID-19, some breast cancer trials have temporarily stopped enrolling new patients. Use the contact information in our trial listings to call or email the research site for information about a trial's status.

Visit COVID-19 & Cancer Clinical Trials on Metastatic Trial Talk for regularly updated information about clinical trials during the coronavirus pandemic.


Currently viewing trials
(Last updated: October 21, 2020)

Zip Code:
 

Narrow my choices:

Radius (miles): All U.S.

20 All U.S.
Early stage    Advanced 
Treatment    Non-treatment 
Phase    I     II     III 
Display Only New Trials 
 
Close
Treatment

BRCA1/2 (inherited)

Chemotherapy

Hormone Therapy

Radiation Oncology

Surgery

Surgery: Reconstruction

Targeted Therapy: All

Targeted Therapy: Anti-HER2 Therapy

Targeted Therapy: CDK Inhibitors

Targeted Therapy: PARP Inhibitors

Targeted Therapy: Tumor Mutations

Targeted Therapy: Other Targeted Therapy

Vaccines and Immunotherapy

Other Treatment

Non-Treatment

Activities

Complementary and Alternative Medicine

Decision Support

Diagnosing Breast Cancer

Genetics/Family History

Having Children

Lymphedema

Managing Side Effects

No Travel Required

Predicting Response to Treatment

Preventing Breast Cancer

Preventing Recurrence

Screening

Support/Education

Surveys/Interviews/Registries

Close

AKT

ALK

AR

BARD1

BRCA1/2 (tumor)

BRIP1

CD205

CD70

CHEK2 or CHEK1

ESR1

FGFR

HER2/ERBB2

HLA

MET or C-Met

NTRK

PALB2

PIK3CA or PI3K

PTEN

RAD51

RAF (including BRAF)

RAS (KRAS or NRAS)

RB

ROS1

TP53

1

NEAREST SITE: 741 miles
University of Arizona
Tucson,AZ

VISITS: 2 visits within 2 months

PHASE: NA

NCT ID: NCT03661892

Syndros to Reduce Pain from Bone Metastases in Stage IV Breast Cancer

Title A Pilot Trial to Evaluate Syndros in Decreasing Opioid Requirement in Patients With Bone Metastases From Breast Cancer Scientific Title

Purpose
To identify the best dose and side effects (good and bad) of Syndros (dronabinol) when used to treat pain from bone metastasis.
Who is this for?
People with metastatic (stage IV) breast cancer that has spread to the bone and have been taking an opioid for bone pain for at least 4 weeks.    Full eligibility criteria
Contact research site
Close

Contact Research Sites

  • What's involved?
  • What's being studied?
  • How can I learn more?
  • <p class="seamTextPara"> You will receive the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Syndros (Dronabinol), by mouth, daily, for 2 months</li> <li class="seamTextUnorderedListItem">Blood and urine samples</li> <li class="seamTextUnorderedListItem">Questionnaires</li> <li class="seamTextUnorderedListItem">Weekly calls</li></ul>
  • <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Syndros is an FDA-approved cannabinoid. </li> <li class="seamTextUnorderedListItem">Cannabinoids are the active chemicals in medical marijuana.</li> <li class="seamTextUnorderedListItem">Syndros is approved to treat patients receiving chemotherapy whose nausea and vomiting are not controlled by other anti-nausea therapies.</li></ul>
  • <ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT03661892' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.practicalpainmanagement.com/resources/news-and-research/fda-approves-syndros-first-liquid-form-cannabinoid-dronabinol' target='_blank'>Practical Pain Management: FDA Approves Syndros, First Liquid Form of Cannabinoid Dronabinol</a> </li><li class='seamTextUnorderedListItem'><a href='https://ww5.komen.org/BreastCancer/ManagingPainRelatedToMetastaticBreastCancer.html' target='_blank'>Practical Pain Management: FDA Approves Syndros, First Liquid Form of Cannabinoid Dronabinol</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.curetoday.com/articles/fda-approves-liquid-formulation-of-thccontaining-drug-for-cinv' target='_blank'>CureToday: FDA Approves Liquid Formulation of THC-Containing Drug for CINV</a> </li></ul>
See more